News

Brief news reports on Tuberculosis

South Africa: MEC Dhlomo to call on everyone to work towards 'Getting to Zero' during this World Aids Day

The MEC for Health Dr Sibongiseni Dhlomo invites the media to the World AIDS Day commemoration where he would be outlining government's Provincial Strategic Plan 2012 - 2016, highlight issues around disability and HIV as well as launch the Men's Forum in Amajuba.

Read More →

‘Legal’ push for illegal TB kits in India

After Chinese mobile phones and toys, it’s the serological test kits from the Dragon that are flooding the Indian market. But more importantly, they are being commercially used rampantly by private medical practitioners to diagnose tuberculosis (TB) in violation of WHO guidelines.

Read More →

Researchers validate preclinical effectiveness of TB drug target that could shorten treatment time

Menlo Park, Calif. — November 29, 2011 — In research at SRI International, scientists evaluating new drug targets against tuberculosis (TB) recently validated the preclinical effectiveness of a target that could rapidly eliminate infections and potentially shorten treatment time. The new drug target is a protein called DNA gyrase B, found in bacteria that cause TB infections.

Read More →

Tuberculosis drug target’s structure to point to new therapies

Scientists at the John Innes Centre led by Dr Stephen Bornemann and Dr Dave Lawson have worked out the structure of a class of enzyme that has been genetically validated as a new drug target in Mycobacterium tuberculosis, a pathogenic bacterium which is responsible for 2 million tuberculosis deaths worldwide each year. The scientists have been awarded over £500,000 by the Biotechnology and Biological Sciences Research Council (BBSRC) to work out how this enzyme works and is regulated, which will help in the development of new therapies against tuberculosis.

Read More →

GDF invites applications for twenty-sixth round of grants

28 November 2011 - Geneva - The Stop TB Partnership's Global Drug Facility (GDF) is inviting applications for its twenty-sixth round of grants.

Read More →

TB vaccination reaching new heights

On a windy Monday morning in Western Kenya, Theresia Anyango and her one-year baby Jeff Otieno calmly follows a counseling session taking place at the Siaya health center.

Read More →

Hyderabad scientists discover TB bacteria killer

A group of Hyderabad scientists has discovered a novel lead molecule that could effectively kill the bacteria that cause tuberculosis, while another group has found that the TB strains circulating in Hyderabad and other parts of Andhra Pradesh are of “ancestral” type and, thus, relatively less damaging in nature.

Read More →

WHO warns of untreatable tuberculosis

The World Health Organisation is warning of the potential for an untreatable form of tuberculosis to develop on Australia's doorstep.

Read More →

TAC facing potentially fatal cash crunch

The TAC is an award winning South African social movement campaigning to save the lives of people living with HIV and TB. In the 12 years since it was established TAC has helped to save and better millions of people's lives in South Africa. It has also contributed to the deepening of democracy in South Africa, through its use of the courts, advocacy and promotion of human rights constitutionalism. Internationally, TAC has been one of the most influential AIDS activist movements; an organisation that has catalysed action on HIV/AIDS across the world. Yet today TAC faces a real threat of imminent closure due to a dire funding crisis.

Read More →

KwaZulu-Natal launches HIV, TB plan

DURBAN -  The KwaZulu-Natal government wants to reduce the transmission of HIV from mother to child to less than 1.4 percent, premier Zweli Mkhize said on Wednesday.

Read More →

Page 617 of 639 · Total posts: 10

←First 616 617 618 Last→